Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Lorne SteinbergMarsh & McLennanMMCDON'T BUYNov 11, 2021

Insurance brokerage business is profitable, but technology will depress margins. Well run, but has benefited from PE expansion. Hard to see the upside. Great company, but rather fully priced.
$163.80

Stock price when the opinion was issued

$161.02

As of Jun 18, 2026. Market Open.

insurance
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

PARTIAL BUY

It consistently earns, a good company. Buy some now and buy some more cheaper.

PAST TOP PICK
(A Top Pick Apr 22/19, Down 7%) If you can get this at $64 he would be very happy.
PAST TOP PICK
(A Top Pick Apr 22/19, Up 21%) It could pull back to 101.60 but he would be a buyer in another $10 dollars.
TOP PICK
Model price of $115.23 which is an 8% upside. This is a solid company. (Analysts’ price target is $106.06)
TOP PICK
$112.32 is his target. Low volatility. Has long owned this and done well with it. Days of rigging bids and price fixing are long behind them. (Analysts’ price target is $93.94)
SELL
(Market Call Minute.) Management is terrible. Margins are under pressure. Would buy Willis Group (WSH-N) instead.
BUY
Probably a pretty reasonable buy right now after their sale of the Putnam Group. By most measures, it is a little undervalued.
BUY
Has gone through a lot of problems in the last 6 months or so. Senior management has been let go and there is talk about people rigging their bidding for certain aspects. The component parts of their company are actually pretty good. New management has cleared up a lot of the issues and thinks there's a lot more upside in this company.
DON'T BUY
Has a hard time understanding exactly what's in it or what the new model will look like. Was extremely profitable. It threw off cash. Had a high ROE. There were things going on that increased the profitability. Would stand back on this one.
DON'T BUY
Model price is $34.64. Prefers other cheaper companies.
WAIT
Have seen earnings estimates fall because of the lack of business that they were going to be getting. Using last Sept's balance sheet, feel that it is worth around $33.45. Want to see the write offs before buying.
DON'T BUY
Is in difficulty. Don't know what the underlying business is going to transform to. Also has a credibility issue.
DON'T BUY
Is in difficulty. Don't know what the underlying business is going to transform to. Also has a credibility issue.
DON'T BUY
A gamble. A wounded stock. Will have some big gyrations day to day.